Focus: Dexcom is a San Diego-based biotech company specializing in continuous glucose monitoring (CGM) devices for diabetes management, representing a market leader in real-time glucose sensing technology. Founded in 1999, the company operates across metabolic disease management with a focus on wearable sensor innovation.
Profile data last refreshed 8h ago · AI intelligence enriched 2w ago
Hot — 368 jobs added in 30d
Net +169 (368 new, 199 removed). Aggressive expansion phase.
Best fit for device engineers, commercial professionals, and manufacturing specialists seeking stable growth in a market-leading platform; less suitable for pharma scientists pursuing traditional drug discovery.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Dexcom
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Dexcom's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
+1 more
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo